<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rosa-Baez C</submitter><funding>Spanish Ministry of University</funding><funding>Redes de Investigación Cooperativa Orientadas a Resultados en Salud</funding><funding>MCIN/AEI/10.13039/501100011033</funding><funding>Miguel Servet</funding><funding>Instituto de Salud Carlos III</funding><funding>FPU</funding><funding>Spanish Ministry of Science Innovation and Universities</funding><pagination>4022-4031</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12107044</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>64(6)</volume><pubmed_abstract>&lt;h4>Objectives&lt;/h4>Coronavirus disease 2019 (COVID-19) and SSc share multiple similarities in their clinical manifestations, alterations in immune response and therapeutic options. These resemblances have also been identified in other immune-mediated inflammatory diseases where a common genetic component has been found. Thus, we decided to evaluate for the first time this shared genetic architecture with SSc.&lt;h4>Methods&lt;/h4>For this study, we retrieved genomic data from two European-ancestry cohorts: 2 597 856 individuals from The COVID-19 Host Genetics Initiative consortium, and 26 679 individuals from the largest genomic scan in SSc. We performed a cross-trait meta-analyses including >9.3 million single nucleotide polymorphisms. Finally, we conducted functional annotation to prioritize p</pubmed_abstract><journal>Rheumatology (Oxford, England)</journal><pubmed_title>Cross-trait GWAS in COVID-19 and systemic sclerosis reveals novel genes implicated in fibrotic and inflammation pathways.</pubmed_title><pmcid>PMC12107044</pmcid><funding_grant_id>RD21/0002/0039</funding_grant_id><funding_grant_id>FPU21/02746</funding_grant_id><funding_grant_id>MICIU/AEI/10.13039/501100011033</funding_grant_id><funding_grant_id>FPU22/01652</funding_grant_id><funding_grant_id>CP21/00132</funding_grant_id><funding_grant_id>PREP2022-000712</funding_grant_id><funding_grant_id>RYC2022-036635-I</funding_grant_id><pubmed_authors>Rosa-Baez C</pubmed_authors><pubmed_authors>Rodriguez-Martin I</pubmed_authors><pubmed_authors>Martin J</pubmed_authors><pubmed_authors>Acosta-Herrera M</pubmed_authors><pubmed_authors>Borrego-Yaniz G</pubmed_authors><pubmed_authors>Kerick M</pubmed_authors><pubmed_authors>Ortiz-Fernandez L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cross-trait GWAS in COVID-19 and systemic sclerosis reveals novel genes implicated in fibrotic and inflammation pathways.</name><description>&lt;h4>Objectives&lt;/h4>Coronavirus disease 2019 (COVID-19) and SSc share multiple similarities in their clinical manifestations, alterations in immune response and therapeutic options. These resemblances have also been identified in other immune-mediated inflammatory diseases where a common genetic component has been found. Thus, we decided to evaluate for the first time this shared genetic architecture with SSc.&lt;h4>Methods&lt;/h4>For this study, we retrieved genomic data from two European-ancestry cohorts: 2 597 856 individuals from The COVID-19 Host Genetics Initiative consortium, and 26 679 individuals from the largest genomic scan in SSc. We performed a cross-trait meta-analyses including >9.3 million single nucleotide polymorphisms. Finally, we conducted functional annotation to prioritize p</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jun</publication><modification>2026-04-26T03:14:27.455Z</modification><creation>2026-04-26T03:08:57.636Z</creation></dates><accession>S-EPMC12107044</accession><cross_references><pubmed>39878951</pubmed><doi>10.1093/rheumatology/keaf028</doi></cross_references></HashMap>